Multi-center, blinded, randomized, PaRallEl-group, Phase 3 study with aproCltentan in Subjects with Resistant HypertensiON (RHT)
- Biswas, Sinjini, (Primary Chief Investigator (PCI))
- Reid, Christopher (Associate Investigator (AI))
- Steer, Caroline, (Associate Investigator (AI))
- Ajani, Andrew (Associate Investigator (AI))
Project: Research